Skip to main content
  • More from ADA
    • Diabetes
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care
  • Subscribe
  • Log in
  • My Cart
  • Follow ada on Twitter
  • RSS
  • Visit ada on Facebook
Diabetes Care

Advanced Search

Main menu

  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • Special Article Collections
    • ADA Standards of Medical Care
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • Special Article Collections
    • ADA Standards of Medical Care
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Journal Policies
    • Instructions for Authors
    • ADA Peer Review
  • More from ADA
    • Diabetes
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care

User menu

  • Subscribe
  • Log in
  • My Cart

Search

  • Advanced search
Diabetes Care
  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • Special Article Collections
    • ADA Standards of Medical Care
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • Special Article Collections
    • ADA Standards of Medical Care
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Journal Policies
    • Instructions for Authors
    • ADA Peer Review
Original Research

Increased CD36 Expression Signals Monocyte Activation Among Patients With Type 2 Diabetes

  1. Yijuan Sun, MD, MS1,
  2. Marina Scavini, MD2,
  3. Robert A. Orlando, PHD3,
  4. Glen H. Murata, MD1,
  5. Karen S. Servilla, MD1,
  6. Antonios H. Tzamaloukas, MD1,
  7. Ronald Schrader, PHD4,
  8. Edward J. Bedrick, PHD2,
  9. Mark R. Burge, MD2,
  10. Nada A. Abumrad, PHD5 and
  11. Philip G. Zager, MD2
  1. 1Department of Medicine, Veteran Affairs Medical Center, Albuquerque, New Mexico;
  2. 2Department of Medicine, University of New Mexico Health Sciences Center, Albuquerque, New Mexico;
  3. 3Department of Biochemistry and Molecular Biology, University of New Mexico Health Sciences Center, Albuquerque, New Mexico;
  4. 4Clinical Translational Sciences Center, University of New Mexico Health Sciences Center, Albuquerque, New Mexico;
  5. 5Department of Medicine, Center for Human Nutrition, Washington University, St. Louis, Missouri.
  1. Corresponding author: Philip G. Zager, pzag{at}unm.edu.
Diabetes Care 2010 Sep; 33(9): 2065-2067. https://doi.org/10.2337/dc10-0460
PreviousNext
  • Article
  • Figures & Tables
  • Info & Metrics
  • PDF
Loading

Article Figures & Tables

Tables

  • Table 1

    Unadjusted and adjusted mean CD36 mRNA/protein and Pearson product moment correlations (r)

    CD36 mRNA (log r.u.)CD36 protein (log r.u.)
    Type 2 diabetesNondiabetic control subjectsType 2 diabetesNondiabetic control subjects
    n33273327
    Unadjusted mean0.23 ± 0.02†0.16 ± 0.020.28 ± 0.02§0.18 ± 0.02
    Model 10.21 ± 0.020.17 ± 0.020.27 ± 0.01*0.21 ± 0.02
    Model 20.20 ± 0.020.18 ± 0.020.26 ± 0.01†0.20 ± 0.01
    CD36 mRNA (log r.u.)NANAr = 0.64‡r = 0.63‡
    PPAR-γ mRNA (log r.u.)r = 0.73‡r = 0.72‡r = 0.33#r = 0.46*
    hsCRP (log mg/dl)r = 0.55†r = 0.21r = 0.45†r = 0.43*
    hsIL-6 (log pg/ml)r = 0.40*r = 0.49†r = 0.64‡r = 0.49†
    TNF-α (log pg/ml)r = −0.20r = 0.09r = −0.28r = −0.02
    Adiponectin (log μg/ml)r = −0.61‡r = −0.67‡r = −0.60‡r = −0.56†
    BMI (kg/m2)r = 0.20r = 0.03r = 0.09r = 0.17
    HOMA-IR (log r.u.)r = 0.18r = 0.03r = 0.12r = −0.07
    QUICKI (log r.u.)r = −0.20r = 0.05r = −0.16r = 0.19
    • Data are least squares means ± SEM unless otherwise indicated. The P value is from a t test of equality of the means. Model 1 adjusts for hypertension (HTN), hsIL-6, PPAR, adiponectin, and QUICKI. Model 2 adjusts for hsIL-6, adiponectin, and QUICKI.

    • ↵*P < 0.05,

    • ↵†P < 0.01,

    • ↵‡P < 0.001,

    • ↵§P < 0.0001,

    • ↵#P = 0.08. HOMA-IR, homeostasis model assessment–insulin resistance; QUICKI, quantitative insulin sensitivity check index; r.u., relative units.

PreviousNext
Back to top
Diabetes Care: 33 (9)

In this Issue

September 2010, 33(9)
  • Table of Contents
  • About the Cover
  • Index by Author
Sign up to receive current issue alerts
View Selected Citations (0)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about Diabetes Care.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Increased CD36 Expression Signals Monocyte Activation Among Patients With Type 2 Diabetes
(Your Name) has forwarded a page to you from Diabetes Care
(Your Name) thought you would like to see this page from the Diabetes Care web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Increased CD36 Expression Signals Monocyte Activation Among Patients With Type 2 Diabetes
Yijuan Sun, Marina Scavini, Robert A. Orlando, Glen H. Murata, Karen S. Servilla, Antonios H. Tzamaloukas, Ronald Schrader, Edward J. Bedrick, Mark R. Burge, Nada A. Abumrad, Philip G. Zager
Diabetes Care Sep 2010, 33 (9) 2065-2067; DOI: 10.2337/dc10-0460

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Add to Selected Citations
Share

Increased CD36 Expression Signals Monocyte Activation Among Patients With Type 2 Diabetes
Yijuan Sun, Marina Scavini, Robert A. Orlando, Glen H. Murata, Karen S. Servilla, Antonios H. Tzamaloukas, Ronald Schrader, Edward J. Bedrick, Mark R. Burge, Nada A. Abumrad, Philip G. Zager
Diabetes Care Sep 2010, 33 (9) 2065-2067; DOI: 10.2337/dc10-0460
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • RESEARCH DESIGN AND METHODS
    • RESULTS
    • CONCLUSIONS
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Tables
  • Info & Metrics
  • PDF

Related Articles

Cited By...

More in this TOC Section

Original Research

  • Risk Factors for Longitudinal Resting Heart Rate and Its Associations With Cardiovascular Outcomes in the DCCT/EDIC Study
  • An Age-Related Exponential Decline in the Risk of Multiple Islet Autoantibody Seroconversion During Childhood
  • Association of Implementation of a Comprehensive Preconception-to-Pregnancy Management Plan With Pregnancy Outcomes Among Chinese Pregnant Women With Type 1 Diabetes: The CARNATION Study
Show more Original Research

Pathophysiology/Complications

  • Insulin Resistance Is Associated With Enhanced Brain Glucose Uptake During Euglycemic Hyperinsulinemia: A Large-Scale PET Cohort
  • Gluconeogenesis, But Not Glycogenolysis, Contributes to the Increase in Endogenous Glucose Production by SGLT-2 Inhibition
  • Day-to-Day Variations in Fasting Plasma Glucose Do Not Influence Gastric Emptying in Subjects With Type 1 Diabetes
Show more Pathophysiology/Complications

Similar Articles

Navigate

  • Current Issue
  • Standards of Care Guidelines
  • Online Ahead of Print
  • Archives
  • Submit
  • Subscribe
  • Email Alerts
  • RSS Feeds

More Information

  • About the Journal
  • Instructions for Authors
  • Journal Policies
  • Reprints and Permissions
  • Advertising
  • Privacy Policy: ADA Journals
  • Copyright Notice/Public Access Policy
  • Contact Us

Other ADA Resources

  • Diabetes
  • Clinical Diabetes
  • Diabetes Spectrum
  • Scientific Sessions Abstracts
  • Standards of Medical Care in Diabetes
  • BMJ Open - Diabetes Research & Care
  • Professional Books
  • Diabetes Forecast

 

  • DiabetesJournals.org
  • Diabetes Core Update
  • ADA's DiabetesPro
  • ADA Member Directory
  • Diabetes.org

© 2021 by the American Diabetes Association. Diabetes Care Print ISSN: 0149-5992, Online ISSN: 1935-5548.